Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Medicaid AMP: Manufacturers Have Reason To Hope For Significant Changes In Final Rule

Jan 13 2014

• By Scott Steinke

Related Content

Drug Makers Must Continue AMP Medicaid Calculations, Despite Court Ruling

Dec 20 2007

Medicaid Rx Stakeholders Appeal To CMS Chief For Help In Reversing AMP Proposal

Apr 05 2012

AMP Rule Answers Questions On Collecting Pricing Data For “5i” Specialty Drugs Raised By Manufacturers

Feb 01 2012

Calculating AMP: Medicaid Proposed Rule Provides Answers, Some Detailed, Some Vague, To Manufacturers’ Questions

Feb 06 2012

Manufacturers See AMP Rule’s “Presumed Inclusion” Proposal As Certainly Challenging

Mar 26 2012

Additional Topics

United States Medicaid BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window